332 related articles for article (PubMed ID: 3274463)
21. Histological changes in renal allografts after successful conversion from cyclosporin A to azathioprine.
Junor BJ; More IA; Bradley JA; Briggs JD; Kyle KF; McGregor E; McMillan MA; Macpherson SG; Van der Merwe W; Rodger RS
Transplant Proc; 1989 Feb; 21(1 Pt 2):1677-9. PubMed ID: 2652549
[No Abstract] [Full Text] [Related]
22. Long-term cyclosporine A treatment does not progressively impair renal graft function: a 5-year follow-up study.
Linder R; Restifo AC; Lindholm A; Groth CG
Transplant Proc; 1991 Aug; 23(4):2210. PubMed ID: 1871848
[No Abstract] [Full Text] [Related]
23. Cyclosporin A treatment with successful selective conversion after six months in 70 renal allograft recipients.
Venning MC; Lennard TW; Stevens ME; Proud G; Ward MK; Elliott RW; Taylor RM; Wilkinson R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1633-4. PubMed ID: 2652533
[No Abstract] [Full Text] [Related]
24. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ
Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
[No Abstract] [Full Text] [Related]
25. Safe conversion from cyclosporine.
Adams PL; Burkart JM; Hamilton RW; Lorentz WB; Browning MC; Meredith JH; Heise ER
Transplant Proc; 1987 Feb; 19(1 Pt 3):2010-1. PubMed ID: 3274464
[No Abstract] [Full Text] [Related]
26. Postoperative endogenous serum cortisol levels as an index of acute rejection and severe infection in renal allograft recipients.
Kozaki M; Hirano T; Oka K; Honma M; Kang X; Sakurai E; Tamaki T; Tamaki I
Transplant Proc; 1989 Feb; 21(1 Pt 2):1864-6. PubMed ID: 2652606
[No Abstract] [Full Text] [Related]
27. Immunohistology or conventional histology for the diagnosis of renal allograft rejection?
McWhinnie DL; Hughes D; Fuggle SV; Dunnill MS; Carter NP; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1888-9. PubMed ID: 2652613
[No Abstract] [Full Text] [Related]
28. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression.
Raine AE; Carter R; Mann JI; Chapman JR; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1820-1. PubMed ID: 3274428
[No Abstract] [Full Text] [Related]
29. Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.
Schilling M; Schleibner S; Abendroth D; Illner WD; Schneeberger H; Land W
Transplant Proc; 1990 Oct; 22(5):2283. PubMed ID: 2219369
[No Abstract] [Full Text] [Related]
30. Renal graft histology in patients treated with different doses of cyclosporine.
Wilczek HE; Bohman SO; Groth CG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1672-3. PubMed ID: 2652547
[No Abstract] [Full Text] [Related]
31. Conversion of cyclosporine to azathroprine in renal transplant recipients.
Bassiri A; Amiranssari B; Gol S
Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877
[No Abstract] [Full Text] [Related]
32. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation.
Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514
[No Abstract] [Full Text] [Related]
33. Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
Beckingham IJ; Dennis MJ; Innes A; Burden RP; Morgan AG; Bishop MC
Transplant Proc; 1993 Apr; 25(2):2100. PubMed ID: 8470283
[No Abstract] [Full Text] [Related]
34. The fate of living related donor kidney recipients after conversion from cyclosporine to azathioprine.
Oka T; Omori Y; Aikawa I; Yasumura T; Nakai I; Matsui S
Transplant Proc; 1987 Feb; 19(1 Pt 3):2012-6. PubMed ID: 3547905
[No Abstract] [Full Text] [Related]
35. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
Wahlberg J; Hanås E; Bergström C; Fellström B; Skarp-Orberg I; Frödin L
Transplant Proc; 1992 Feb; 24(1):311-2. PubMed ID: 1539291
[No Abstract] [Full Text] [Related]
36. Long-term prognosis of cadaver renal allografts transplanted with cyclosporine as basic immunosuppression. The Leuven Collaborative Group for Transplantation.
Vanrenterghem Y; Waer M; Roels L; Christiaens R; Gruwez J; Michielsen P
Transplant Proc; 1990 Aug; 22(4):1691-2. PubMed ID: 2389434
[No Abstract] [Full Text] [Related]
37. Cyclosporine in cadaveric renal transplantation: a comparison of two immunosuppressive protocols.
Koyle M; Glassock R; Rajfer J; Ward H
Transplant Proc; 1987 Feb; 19(1 Pt 3):1849. PubMed ID: 3079048
[No Abstract] [Full Text] [Related]
38. Fractional excretion of sodium is an early predictor of cyclosporine nephrotoxicity after renal transplantation.
Morales JM; Andrés A; Hernández E; Prieto C; Ortuño T; Montoyo C; Moreno F; Rodriguez-Paternina E; Farías J; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1728-9. PubMed ID: 2389444
[No Abstract] [Full Text] [Related]
39. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
40. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
